RIGEL PHARMACEUTICALS INC Quarterly Interest Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q3 2024.
  • Rigel Pharmaceuticals Inc Interest Expense for the quarter ending September 30, 2024 was $2.06M, a 8.48% increase year-over-year.
  • Rigel Pharmaceuticals Inc Interest Expense for the twelve months ending September 30, 2024 was $7.87M, a 29.6% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Interest Expense for 2023 was $6.87M, a 85.4% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Interest Expense for 2022 was $3.71M, a 23.7% decline from 2021.
  • Rigel Pharmaceuticals Inc annual Interest Expense for 2021 was $4.86M, a 259% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.87M $2.06M +$161K +8.48% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.71M $2.03M +$167K +8.97% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $7.54M $1.87M +$670K +55.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.87M $1.91M +$800K +72.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $6.07M $1.9M +$1.07M +130% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $5M $1.86M +$1.29M +227% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $3.71M $1.2M -$1K -0.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $3.71M $1.11M -$192K -14.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $3.9M $826K -$491K -37.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $4.39M $569K -$1.19M -67.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $5.58M $1.21M +$720K +148% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $4.86M $1.3M +$870K +203% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $3.99M $1.32M +$888K +207% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.1M $1.76M +$1.41M +398% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $1.7M $485K +$343K +242% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $1.35M $429K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $429K +$421K +5263% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $353K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $142K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q3 2019 $8K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q1 2012 $14K $0 -$11K -100% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $25K $3K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 $4K -$11K -73.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $7K -$18K -72% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $11K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q3 2010 $15K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 $25K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.